Top Markets
Coin of the day
Beta Bionics, Inc. Beta Bionics, Inc.

Beta Bionics, Inc.

BBNX
Kedudukan dalam Saham #10096
Beta Bionics, Inc. is a commercial-stage medical technology company dedicated... Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently available for treating type 1 diabetes in adults and children aged six and older. In addition to its existing offering, Beta Bionics is actively developing several new innovations: a Patch Pump, designed as a tubeless insulin pump that adheres directly to the skin; the Bihormonal iLet, which integrates automated delivery of both insulin and glucagon; and an iLet system specifically adapted for individuals with insulin-dependent type 2 diabetes. To support its product pipeline, the company has forged strategic alliances, including a collaboration and licensing agreement with Xeris Pharmaceuticals, Inc. to develop and commercialize a glucagon formulation compatible with pumps. It also holds a development and commercialization agreement with Abbott Diabetes Care Inc. for an automated insulin delivery system. Established in 2015, Beta Bionics is headquartered in Irvine, California.
Harga Saham
$19.81
Disegerakkan terakhir: 2026-08-28
Modal Pasaran
$891.32M
Perubahan (1 hari)
1.39%
Perubahan (1 tahun)
5.16%
Negara
US
Perdagangan Beta Bionics, Inc. (BBNX)

Kategori

Harga BBNX dengan permodalan pasaran b
Beta Bionics, Inc. Beta Bionics, Inc.
BBNX
$19.81
Modal pasaran bagi Beta Bionics, Inc.(BBNX)
Modal Pasaran: $891.32M
Sehingga August 2026, Beta Bionics, Inc. mempunyai modal pasaran sebanyak $891.32M. Ini menjadikan Beta Bionics, Inc. syarikat ke-10096th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Beta Bionics, Inc. dari 2025 hingga 2026
BBNX berbanding dengan 5 teratas yang paling popular stocks
Harga BBNX Aset B Pasaran B Hasilnya
Beta Bionics, Inc. Beta Bionics, Inc.
$117,002 $891.32M
$5.264T +590,468.44%
Beta Bionics, Inc. Beta Bionics, Inc.
$104,497 $891.32M
$4.701T +527,349.64%
Beta Bionics, Inc. Beta Bionics, Inc.
$92,847.45 $891.32M
$4.177T +468,549.57%
Beta Bionics, Inc. Beta Bionics, Inc.
$84,850.58 $891.32M
$3.817T +428,185.19%
Beta Bionics, Inc. Beta Bionics, Inc.
$63,710.97 $891.32M
$2.866T +321,482.56%